Category

UF Innovate | Accelerate

UF Graduate Student Start-Up Focuses on Creating Chemicals From Ocean Microbes

In Jules Verne’s 20,000 Leagues Under the Sea, Captain Nemo describes the sea as “everything,” the “vast reservoir of Nature.” A pair of UF Ph.D. students are diving into these vast depths. They are harnessing the power of marine microbes and unlocking their potential for sustainable chemical applications. Jessica Tittl Nielsen (CEO) and Monica Schul (Chief Science Officer) founded a biotechnology company, Cordelia Biosciences, to create sustainable chemicals from ocean microbes.

GatorX Advances to Semi-Final Round of XPRIZE Track B Autonomous Wildfire Challenge

Fire Neural Network (FNN) announced that their team, GatorX, is advancing to the semi-final round of the XPRIZE Track B Autonomous Wildfire Challenge. GatorX is a well-rounded partnership between Fire Neural Network, the University of Florida, NVIDIA, SATLANTIS, SwissDrones, Archer Aviation, SWIR Vision Systems, and N5 Sensors.

JPMorgan Upgrades Solid Biosciences Stock, Sees Growth Potential

JPMorgan upgraded Solid Biosciences stock, a biotechnology company that acquired UF startup AavantiBio, from Neutral to Overweight, and increased the price target to $15.00 from the previous $10.00. The firm's decision reflects a positive outlook on the company's prospects, particularly with upcoming developments expected in the fourth quarter.

Dr. Read Hayes of the LPRC Is Recognized as a Global Thought Leader

The Life Safety Alliance (LSA), an organization dedicated to enhancing global life safety and security through partnerships and collaborations, has announced the results of its Top 40 Global Thought Leaders in Security and Life Safety. UF Innovate | Accelerate client Loss Prevention Research Council's Read Hayes is recognized as a global thought leader.

Oragenics Develops Automated Intranasal Device for Treating Concussed Patients

Oragenics, Inc., a UF Innovate | Accelerate alumnus company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced it has completed a prototype of its automated intranasal device for use in concussed patients who are initially confused, dazed or unconscious in the acute phase of injury.